Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Inflammation 2Hyperuricemia 1Gout 1Cardiovascular Diseases 1Barrett Esophagus 1Arthritis 1

Interventions

Omeprazole 2soybean oil, phospholipid emulsion 1dolutegravir 1Vitamin D 1Tumor Necrosis Factors 1Trimethoprim, Sulfamethoxazole Drug Combination 1Sufentanil 1Sodium Chloride 1Ritonavir 1Riluzole 1Oxycodone 1Nutrition Assessment 1Nucleosides 1Naproxen 1Infliximab 1Fish Oils 1Febuxostat 1Exercise 1Diet 1Dexlansoprazole 1Darunavir 1Colchicine 1Clindamycin 1ClinOleic 1Cephalexin 1Anti-Bacterial Agents 1Allopurinol 1Acetylcysteine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Inflammation × Omeprazole × Clear all
NCT02500641 2019-06-21

FORWARD

Menarini International Operations Luxembourg SA

Phase 4 Completed
196 enrolled 9 charts

Arthritis, Cardiovascular Diseases, Gout, Inflammation, Hyperuricemia

NCT01093755 2016-03-17

Does Intensive Acid Suppression Reduce Esophageal Inflammation and Recurrent Barrett's Esophagus Following Ablation?

Mayo Clinic

Phase 4 Completed
30 enrolled 12 charts
Gastrointestinal

Barrett Esophagus, Inflammation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡